title: Outcomes from rectal vancomycin therapy in patients with Clostridium difficile infection.
authors.affiliation: Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: George
authors.initials: G
authors.lastname: Saffouri
authors.affiliation: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Sahil
authors.initials: S
authors.lastname: Khanna
authors.affiliation: Hospital Pharmacy Services, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Lynn
authors.initials: L
authors.lastname: Estes
authors.affiliation: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Darrell
authors.initials: D
authors.lastname: Pardi
mesh_terms: D000285:Administration, Rectal; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016360:Clostridioides difficile / Q000187:drug effects*; D004359:Drug Therapy, Combination; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D014640:Vancomycin / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D008795:Metronidazole; D014640:Vancomycin